
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter E - Animal Drugs, Feeds, and Related Products
#### PART 500 - GENERAL
##### Subpart E - Regulation of Carcinogenic Compounds Used in Food-Producing Animals
###### ยง 500.88 Regulatory method.

(a) The sponsor shall submit for evaluation and validation a regulatory method developed to monitor compliance with FDA's operational definition of no residue.

(b) The regulatory method must be able to confirm the identity of the marker residue in the target tissue at a minimum concentration corresponding to the R. FDA will determine the LOD from the submitted analytical method validation data.

(c) FDA will publish in thethe complete regulatory method for ascertaining the marker residue in the target tissue in accordance with the provisions of sections 409(c)(3)(A), 512(d)(1)(I), and 721(b)(5)(B) of the act.

(d) If the sponsor initially submitted a request for an import tolerance under ยง 510.205 of this chapter, FDA will make the complete regulatory method for ascertaining the marker residue in the target tissue publicly available pursuant to ยง 510.207(b) of this chapter.
